Reneo Pharmaceuticals Stock Price Prediction

RPHM Stock  USD 1.66  0.01  0.61%   
As of now, the RSI of Reneo Pharmaceuticals' share price is approaching 43 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Reneo Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

43

 
Oversold
 
Overbought
Reneo Pharmaceuticals stock price prediction is an act of determining the future value of Reneo Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Reneo Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Reneo Pharmaceuticals and does not consider all of the tangible or intangible factors available from Reneo Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Reneo Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Reneo Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.55)
EPS Estimate Current Year
(2.37)
EPS Estimate Next Year
(0.79)
Wall Street Target Price
1.74
EPS Estimate Current Quarter
(0.57)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Reneo Pharmaceuticals based on different types of headlines from major news networks to social media. The Reneo stock price prediction module provides an analysis of price elasticity to changes in media outlook on Reneo Pharmaceuticals over a specific investment horizon. Using Reneo Pharmaceuticals hype-based prediction, you can estimate the value of Reneo Pharmaceuticals from the perspective of Reneo Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Reneo Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Reneo Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Reneo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Reneo Pharmaceuticals after-hype prediction price

    
  USD 1.65  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Reneo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reneo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
1.497.609.40
Details
5 Analysts
Consensus
LowTargetHigh
23.4025.7128.54
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.61-0.58-0.56
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Reneo Pharmaceuticals. Your research has to be compared to or analyzed against Reneo Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Reneo Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Reneo Pharmaceuticals.

Reneo Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Reneo Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Reneo Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Reneo Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Reneo Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Reneo Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Reneo Pharmaceuticals' historical news coverage. Reneo Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.08 and 3.45, respectively. We have considered Reneo Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.66
1.65
After-hype Price
3.45
Upside
Reneo Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Reneo Pharmaceuticals is based on 3 months time horizon.

Reneo Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Reneo Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Reneo Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Reneo Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.07 
1.80
 0.00  
  0.17 
5 Events / Month
3 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.66
1.65
0.00 
6,000  
Notes

Reneo Pharmaceuticals Hype Timeline

Reneo Pharmaceuticals is at this time traded for 1.66. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.17. Reneo is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.07%. %. The volatility of related hype on Reneo Pharmaceuticals is about 72.87%, with the expected price after the next announcement by competition of 1.49. About 82.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.48. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Reneo Pharmaceuticals recorded a loss per share of 2.36. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days.
Check out Reneo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.

Reneo Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Reneo Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Reneo Pharmaceuticals' future price movements. Getting to know how Reneo Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Reneo Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TFXTeleflex Incorporated(0.68)10 per month 0.00 (0.19) 2.40 (2.40) 9.27 
MSADYMSAD Insurance Group 0.00 0 per month 0.55  0.19  3.97 (1.75) 15.24 
RDNTRadNet Inc 0.55 8 per month 1.50  0.13  4.42 (2.86) 21.32 
VALNValneva SE ADR 0.27 7 per month 0.00 (0.12) 5.47 (4.94) 19.42 
KNSLKinsale Capital Group(17.23)12 per month 0.78  0.25  3.44 (1.70) 19.17 
MTGMGIC Investment Corp(0.19)10 per month 0.85  0.06  2.09 (1.86) 7.58 
NODKNI Holdings(0.01)8 per month 0.97  0.06  1.89 (2.16) 10.26 

Reneo Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Reneo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Reneo using various technical indicators. When you analyze Reneo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Reneo Pharmaceuticals Predictive Indicators

The successful prediction of Reneo Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Reneo Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Reneo Pharmaceuticals based on analysis of Reneo Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Reneo Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Reneo Pharmaceuticals's related companies.
 2023 2024 (projected)
Interest Coverage25.622.76
Total Debt To Capitalization0.01660.0158

Story Coverage note for Reneo Pharmaceuticals

The number of cover stories for Reneo Pharmaceuticals depends on current market conditions and Reneo Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Reneo Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Reneo Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Reneo Pharmaceuticals Short Properties

Reneo Pharmaceuticals' future price predictability will typically decrease when Reneo Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Reneo Pharmaceuticals often depends not only on the future outlook of the potential Reneo Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Reneo Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding24.5 M
Cash And Short Term Investments101.2 M
When determining whether Reneo Pharmaceuticals is a strong investment it is important to analyze Reneo Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reneo Pharmaceuticals' future performance. For an informed investment choice regarding Reneo Stock, refer to the following important reports:
Check out Reneo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.
Note that the Reneo Pharmaceuticals information on this page should be used as a complementary analysis to other Reneo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Reneo Stock analysis

When running Reneo Pharmaceuticals' price analysis, check to measure Reneo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reneo Pharmaceuticals is operating at the current time. Most of Reneo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reneo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reneo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reneo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Reneo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.36)
Return On Assets
(0.36)
Return On Equity
(0.59)
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.